Aleksandar Jankov, MD, a Baptist Cancer Center oncologist, has completed training to administer Imlygic, a new treatment for melanoma. The therapy is a genetically modified oncolytic for the treatment of unresectable cutaneous, subcutaneous, and nodal lesions in patients with melanoma recurrent after initial surgery. For more information or to schedule a consultation with Dr. Jankov, contact him at aleksandar.jankov@bmg.md.
New Treatment for Melanoma Now Available
Aleksandar Jankov, MD, a Baptist Cancer Center oncologist, has completed training to administer Imlygic, a new treatment for melanoma.
Related Articles
-
Four Baptist Memorial Hospitals Earn an “A” Hospital Safety Grade for Fall 2024
-
Aim to Maintain 2024 Offers Classes, Workshops and Prizes
-
BCC Sponsors Making Strides Against Breast Cancer of Central Mississippi
-
Baptist DeSoto Team Members Compete in Pumpkin Decorating Contest
-
Josh Creason to Speak at November Preaching Series